Generative AI-Based Evaluation of Clinical Thinking and Decision-Making in Medical Students
Construction of an Intelligent Evaluation System for Clinical Thinking and Decision-making Ability of Medical Students Based on Generative Artificial Intelligence
The goal of this study is to develop and evaluate an intelligent system based on generative artificial intelligence (AI) for assessing clinical thinking and decision-making abilities in medical students.
The study will examine whether the AI-based evaluation system can provide reliable and valid assessments of medical students' performance in clinical scenarios. Participants will complete clinical case-based tasks designed to assess their clinical reasoning and decision-making abilities. Their responses will be evaluated using the AI-based system and compared with assessments made using established evaluation methods and/or expert ratings.
The findings of this study may help determine whether generative AI can be used as a practical tool for assessing clinical thinking and decision-making skills in medical education.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
This study aims to develop and evaluate a generative artificial intelligence-based system for assessing clinical thinking and decision-making abilities in medical students. Clinical reasoning and decision-making are core competencies in medical education, but conventional assessment methods often require substantial faculty time and may be influenced by differences among evaluators.
The study will develop an intelligent evaluation framework using generative artificial intelligence to analyze medical students' responses to clinical case-based tasks. The system will assess key aspects of clinical thinking and decision-making, such as information interpretation, diagnostic reasoning, selection of appropriate management strategies, and overall decision-making logic.
Medical students participating in the study will complete standardized clinical scenarios or case-based assessment tasks. Their performance will be evaluated using the artificial intelligence-based system and compared with evaluations made by qualified clinical experts and/or established assessment methods. The study will examine the reliability, validity, consistency, and feasibility of the artificial intelligence-based evaluation approach.
The purpose of this study is to determine whether generative artificial intelligence can serve as a reliable and practical tool for evaluating clinical thinking and decision-making abilities in medical education. The system is intended for educational assessment and is not designed to replace clinical diagnosis or treatment decisions.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Zhejiang
-
Hangzhou, Zhejiang, Porcelana, 310000
- Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Aged 18 to 30 years.
- Fourth- or fifth-year undergraduate students majoring in Clinical Medicine at Zhejiang University School of Medicine, or trainees who have completed at least one year of standardized residency training at Sir Run Run Shaw Hospital, Zhejiang University School of Medicine.
- Have completed basic surgery courses and theoretical learning related to breast diseases.
- Voluntarily agree to participate in the study and provide written informed consent.
- Have adequate communication and comprehension abilities.
Exclusion Criteria:
- Have previously participated in similar generative artificial intelligence (GAI)-based teaching intervention studies.
- Are unable to complete the entire study because of rotation schedules or other conflicts.
- Belong to vulnerable populations other than employees of the study institution or subordinates of the investigators, including individuals with mental illness, cognitive impairment, critical illness, pregnancy, or illiteracy.
- Refuse or are unwilling to provide informed consent.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: Control Group: Traditional Teaching
the standardized surgical oncology teaching curriculum, utilizing standardized breast cancer teaching PowerPoint courseware. |
Participants will receive standard traditional teaching, including routine classroom instruction, case-based learning, and teacher-guided discussion, without the use of the generative artificial intelligence-assisted learning component. |
|
Experimental: Intervention Group: Traditional Teaching Plus AI Assistance
the independently developed "Clinical Reasoning and Decision-Making Dialogue Evaluation System" on the basis of the same traditional teaching. |
Participants will receive standard traditional teaching, including routine classroom instruction, case-based learning, and teacher-guided discussion, without the use of the generative artificial intelligence-assisted learning component. The intervention consists of traditional medical education supplemented with a generative artificial intelligence-based learning tool. The tool will support students in clinical case analysis, reasoning, and decision-making exercises. The control group will receive the same traditional teaching without access to the AI-assisted learning component. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Clinical Reasoning Score on Objective Structured Clinical Examination (OSCE)
Periodo de tiempo: Baseline to Week 4
|
The total score ranges from 0 to 100. A higher score indicates better clinical thinking and decision-making ability |
Baseline to Week 4
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Intraclass Correlation Coefficient (ICC) Between GAI-Based and Expert Assessment Scores
Periodo de tiempo: Baseline to Week 4
|
Both Generative AI (GAI) and human experts will evaluate the participants using the clinical Reasoning Assessment Rubric. The agreement between the GAI-based scores and expert assessment scores will be evaluated using the Intraclass Correlation Coefficient (ICC) . The coefficient ranges from 0 to 1, where higher values indicate better agreement. |
Baseline to Week 4
|
|
Time to Complete the Assessment
Periodo de tiempo: During the clinical thinking and decision-making assessment at Week 4 (completion time measured in minutes).
|
Assessment completion time is defined as the duration, measured in minutes, from the initiation of the clinical thinking and decision-making assessment to its final submission by the participant. The time will be automatically recorded by the evaluation platform. Each participant's assessment completion time will be measured during the assessment conducted at Week 4. |
During the clinical thinking and decision-making assessment at Week 4 (completion time measured in minutes).
|
|
Participant Satisfaction Score on the GAI-Assisted Evaluation System
Periodo de tiempo: Week 4
|
Participant satisfaction will be measured using a 5-point Likert scale (ranging from 1 = Very Dissatisfied to 5 = Very Satisfied). A higher score indicates higher satisfaction with the GAI-assisted evaluation system. |
Week 4
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- Research 2025734
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .